annual working capital:
$592.30M+$281.29M(+90.44%)Summary
- As of today (May 29, 2025), ARWR annual working capital is $592.30 million, with the most recent change of +$281.29 million (+90.44%) on September 30, 2024.
- During the last 3 years, ARWR annual working capital has risen by +$354.24 million (+148.80%).
- ARWR annual working capital is now at all-time high.
Performance
ARWR Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$914.68M+$437.90M(+91.85%)Summary
- As of today (May 29, 2025), ARWR quarterly working capital is $914.68 million, with the most recent change of +$437.90 million (+91.85%) on March 31, 2025.
- Over the past year, ARWR quarterly working capital has increased by +$438.20 million (+91.97%).
- ARWR quarterly working capital is now at all-time high.
Performance
ARWR quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
ARWR Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.4% | +92.0% |
| 3 y3 years | +148.8% | +228.1% |
| 5 y5 years | +252.2% | +250.3% |
ARWR Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.8% | at high | +425.1% |
| 5 y | 5-year | at high | +252.2% | at high | +425.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ARWR Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $914.68M(+91.8%) |
| Dec 2024 | - | $476.78M(-19.5%) |
| Sep 2024 | $592.30M(+90.4%) | $592.30M(+67.6%) |
| Jun 2024 | - | $353.35M(-25.8%) |
| Mar 2024 | - | $476.48M(+173.6%) |
| Dec 2023 | - | $174.18M(-44.0%) |
| Sep 2023 | $311.02M(+16.7%) | $311.02M(-22.2%) |
| Jun 2023 | - | $399.94M(-18.0%) |
| Mar 2023 | - | $487.66M(+7.7%) |
| Dec 2022 | - | $452.99M(+70.0%) |
| Sep 2022 | $266.45M(+11.9%) | $266.45M(-12.4%) |
| Jun 2022 | - | $304.18M(+9.1%) |
| Mar 2022 | - | $278.77M(+38.5%) |
| Dec 2021 | - | $201.25M(-15.5%) |
| Sep 2021 | $238.06M(-15.5%) | $238.06M(-28.0%) |
| Jun 2021 | - | $330.52M(-21.2%) |
| Mar 2021 | - | $419.57M(+40.5%) |
| Dec 2020 | - | $298.62M(+6.0%) |
| Sep 2020 | $281.69M(+67.5%) | $281.69M(+3.4%) |
| Jun 2020 | - | $272.45M(+4.3%) |
| Mar 2020 | - | $261.14M(-39.8%) |
| Dec 2019 | - | $433.92M(+158.0%) |
| Sep 2019 | $168.18M(+153.3%) | $168.18M(+6.8%) |
| Jun 2019 | - | $157.45M(+18.2%) |
| Mar 2019 | - | $133.16M(+16.5%) |
| Dec 2018 | - | $114.34M(+72.2%) |
| Sep 2018 | $66.40M(+35.0%) | $66.40M(+21.3%) |
| Jun 2018 | - | $54.74M(-34.5%) |
| Mar 2018 | - | $83.54M(+112.1%) |
| Dec 2017 | - | $39.39M(-19.9%) |
| Sep 2017 | $49.20M(-24.1%) | $49.20M(-14.6%) |
| Jun 2017 | - | $57.58M(-7.3%) |
| Mar 2017 | - | $62.14M(-10.2%) |
| Dec 2016 | - | $69.23M(+6.7%) |
| Sep 2016 | $64.86M(-25.4%) | $64.86M(+86.6%) |
| Jun 2016 | - | $34.76M(-33.3%) |
| Mar 2016 | - | $52.09M(-25.5%) |
| Dec 2015 | - | $69.96M(-19.6%) |
| Sep 2015 | $86.97M(-39.2%) | $86.97M(-17.3%) |
| Jun 2015 | - | $105.16M(-1.7%) |
| Mar 2015 | - | $106.94M(-11.4%) |
| Dec 2014 | - | $120.67M(-15.6%) |
| Sep 2014 | $142.95M(+610.6%) | $142.95M(-7.9%) |
| Jun 2014 | - | $155.17M(+2.5%) |
| Mar 2014 | - | $151.44M(+124.7%) |
| Dec 2013 | - | $67.39M(+235.0%) |
| Sep 2013 | $20.12M(+1523.3%) | $20.12M(-27.5%) |
| Jun 2013 | - | $27.73M(-909.9%) |
| Mar 2013 | - | -$3.42M(>+9900.0%) |
| Dec 2012 | - | -$14.00K(-101.1%) |
| Sep 2012 | $1.24M | $1.24M(+1314.8%) |
| Jun 2012 | - | $87.60K(-96.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $2.44M(-40.6%) |
| Dec 2011 | - | $4.11M(-43.5%) |
| Sep 2011 | $7.28M(+88.8%) | $7.28M(+48.9%) |
| Jun 2011 | - | $4.89M(-19.7%) |
| Mar 2011 | - | $6.09M(+93.9%) |
| Dec 2010 | - | $3.14M(-18.6%) |
| Sep 2010 | $3.86M(+2667.8%) | $3.86M(-22.7%) |
| Jun 2010 | - | $4.99M(+601.4%) |
| Mar 2010 | - | $710.80K(-54.7%) |
| Dec 2009 | - | $1.57M(+1026.1%) |
| Sep 2009 | $139.30K(-98.0%) | $139.30K(-121.3%) |
| Jun 2009 | - | -$655.00K(+141.5%) |
| Mar 2009 | - | -$271.20K(-106.5%) |
| Dec 2008 | - | $4.16M(-39.1%) |
| Sep 2008 | $6.83M(-69.5%) | $6.83M(-43.0%) |
| Jun 2008 | - | $11.99M(-34.3%) |
| Mar 2008 | - | $18.25M(-23.7%) |
| Dec 2007 | - | $23.92M(+6.8%) |
| Sep 2007 | $22.41M(-13.3%) | $22.41M(-23.2%) |
| Jun 2007 | - | $29.17M(+36.6%) |
| Mar 2007 | - | $21.35M(-23.2%) |
| Dec 2006 | - | $27.79M(+7.5%) |
| Sep 2006 | $25.86M(+18.7%) | $25.86M(-12.7%) |
| Jun 2006 | - | $29.61M(-11.7%) |
| Mar 2006 | - | $33.52M(+85.6%) |
| Dec 2005 | - | $18.06M(-17.1%) |
| Sep 2005 | $21.79M(+147.4%) | $21.79M(-11.7%) |
| Jun 2005 | - | $24.67M(+170.4%) |
| Mar 2005 | - | $9.12M(+31.0%) |
| Dec 2004 | - | $6.96M(-21.0%) |
| Sep 2004 | $8.81M(+521.2%) | $8.81M(-16.6%) |
| Jun 2004 | - | $10.56M(-7.8%) |
| Mar 2004 | - | $11.46M(+444.3%) |
| Dec 2003 | - | $2.11M(+48.5%) |
| Sep 2003 | $1.42M(-191.2%) | $1.42M(-180.9%) |
| Jun 2003 | - | -$1.75M(+3.0%) |
| Mar 2003 | - | -$1.70M(+6.4%) |
| Dec 2002 | - | -$1.60M(+2.9%) |
| Sep 2002 | -$1.55M(+22.2%) | -$1.55M(+5.6%) |
| Jun 2002 | - | -$1.47M(+9.1%) |
| Mar 2002 | - | -$1.35M(+1.0%) |
| Dec 2001 | - | -$1.34M(+5.0%) |
| Sep 2001 | -$1.27M(+11.6%) | -$1.27M(+5.2%) |
| Jun 2001 | - | -$1.21M(+2.9%) |
| Mar 2001 | - | -$1.17M(+0.5%) |
| Dec 2000 | - | -$1.17M(+2.6%) |
| Sep 2000 | -$1.14M(+12.9%) | -$1.14M(-3.0%) |
| Jun 2000 | - | -$1.17M(+4.8%) |
| Mar 2000 | - | -$1.12M(+4.8%) |
| Dec 1999 | - | -$1.07M |
| Sep 1999 | -$1.01M(-64.2%) | - |
| Sep 1998 | -$2.82M(+6.3%) | - |
| Sep 1997 | -$2.65M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual working capital year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly working capital year-on-year change?
What is Arrowhead Pharmaceuticals annual working capital?
The current annual working capital of ARWR is $592.30M
What is the all time high annual working capital for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual working capital is $592.30M
What is Arrowhead Pharmaceuticals annual working capital year-on-year change?
Over the past year, ARWR annual working capital has changed by +$281.29M (+90.44%)
What is Arrowhead Pharmaceuticals quarterly working capital?
The current quarterly working capital of ARWR is $914.68M
What is the all time high quarterly working capital for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly working capital is $914.68M
What is Arrowhead Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ARWR quarterly working capital has changed by +$438.20M (+91.97%)